STING1 and viral infectious disease: To evaluate whether the pre-activation of the STING pathway can suppress susceptibility to C-REV infection, Capan-2 cells were treated with 2′3′-cGAMP at 5 μM 1 h, before viral infection, followed by MTT assay.